tradingkey.logo
搜尋

Enovis Corp

ENOV
添加自選
29.150USD
-0.140-0.48%
收盤 07-31 16:00美東報價延遲15分鐘
1.68B總市值
虧損本益比TTM

關於 Enovis Corp 公司

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

Enovis Corp簡介

公司代碼ENOV
公司名稱Enovis Corp
上市日期May 08, 2008
CEOMcdonald (Damien)
員工數量7367
證券類型Ordinary Share
年結日May 08
公司地址2711 Centerville Road
城市WILMINGTON
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編19808
電話13022529160
網址https://www.enovis.com/
公司代碼ENOV
上市日期May 08, 2008
CEOMcdonald (Damien)

Enovis Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
19.22K
+4.40%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
17.60K
+53.09%
Mr. A. Clayton Perfall
Mr. A. Clayton Perfall
Independent Director
Independent Director
--
--
Mr. Brady R. Shirley
Mr. Brady R. Shirley
Director
Director
--
--
Mr. Bradley J. (Brad) Tandy, J.D.
Mr. Bradley J. (Brad) Tandy, J.D.
Senior Vice President, Chief Legal Officer
Senior Vice President, Chief Legal Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
19.22K
+4.40%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%

常見問題

Enovis Corp的前五大股東是誰?

Enovis Corp的前五大股東如下:Mr. Daniel Alexis Pryor

有多少機構持有Enovis Corp(ENOV)的股份?

截至2026Q1,共有652家機構持有Enovis Corp的股份,合計持有的股份價值約為68.97M,占公司總股份的119.81% 。與2025Q4相比,機構持股有所增加,增幅為-6763998.00。

哪個業務部門對Enovis Corp的收入貢獻最大?

在2026Q1,Medical Technology-Prevention & Rehabilitation業務部門對Enovis Corp的收入貢獻最大,創收1.14B,占總收入的50.58% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有